AcuraBio expands cGMP plasmid DNA CDMO services with Cytiva’s latest single-use purification technology to alleviate supply constraints for mRNA and cell & gene therapies

February 9, 2023

Brisbane, Australia – AcuraBio, a leading Australian biopharmaceutical contract development and manufacturing organization (CDMO), will provide a cGMP plasmid DNA...

Executive Appointments

AcuraBio Announces Appointment of VP Business Development at Biotech Showcase 2023

January 9, 2023

Brisbane, Australia – AcuraBio, the leading Australian biopharmaceutical CDMO, recently acquired by biotech investor Dr. Glenn Haifer and Ampersand Capital...